Estatísticas para RT 2371 2021 - ranibizumab; aflibercept; bevacizumab - Degeneração macular diabética - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 2371 2021 - ranibizumab; aflibercept; bevacizumab - Degeneração macular diabética - NATJUS TJMG | 11 |
Total visitas por mês
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 1 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 2 |
| November 2025 | 0 |
Visitas Arquivos
| views | |
|---|---|
| RT 2021.0002371 - EMD Avastin (2).pdf | 9 |